Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma.
Gelli E, Soncini D, Becherini P, Martinuzzi C, Todoerti K, Cagnetta A, Aquino S, Guolo F, Miglino M, Bruzzone S, Nencioni A, Neri A, Lemoli RM, Cea M.
Gelli E, et al. Among authors: neri a.
Blood Adv. 2023 Jul 25;7(14):3472-3478. doi: 10.1182/bloodadvances.2022009035.
Blood Adv. 2023.
PMID: 36897214
Free PMC article.
No abstract available.